AKRO vs. SPY
Compare and contrast key facts about Akero Therapeutics, Inc. (AKRO) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AKRO or SPY.
Correlation
The correlation between AKRO and SPY is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AKRO vs. SPY - Performance Comparison
Key characteristics
AKRO:
1.31
SPY:
1.99
AKRO:
3.67
SPY:
2.66
AKRO:
1.41
SPY:
1.36
AKRO:
2.17
SPY:
3.02
AKRO:
7.17
SPY:
12.56
AKRO:
20.80%
SPY:
2.02%
AKRO:
114.35%
SPY:
12.74%
AKRO:
-79.99%
SPY:
-55.19%
AKRO:
-5.33%
SPY:
-1.96%
Returns By Period
In the year-to-date period, AKRO achieves a 93.57% return, which is significantly higher than SPY's 1.99% return.
AKRO
93.57%
90.69%
126.26%
158.77%
15.68%
N/A
SPY
1.99%
0.98%
16.28%
22.47%
14.20%
13.27%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AKRO vs. SPY — Risk-Adjusted Performance Rank
AKRO
SPY
AKRO vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Akero Therapeutics, Inc. (AKRO) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AKRO vs. SPY - Dividend Comparison
AKRO has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.18%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AKRO Akero Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.18% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
AKRO vs. SPY - Drawdown Comparison
The maximum AKRO drawdown since its inception was -79.99%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for AKRO and SPY. For additional features, visit the drawdowns tool.
Volatility
AKRO vs. SPY - Volatility Comparison
Akero Therapeutics, Inc. (AKRO) has a higher volatility of 70.37% compared to SPDR S&P 500 ETF (SPY) at 4.00%. This indicates that AKRO's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.